Millennium Management’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Millennium Management’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-625,504	Closed	-$6.29M	–	7214
2022 Q4	$6.29M	Buy	625,504 +67,821	+12%	+$675K	﹤0.01%	2611
2022 Q3	$5.49M	Buy	557,683 +120,819	+28%	+$1.19M	﹤0.01%	2804
2022 Q2	$4.25M	Buy	436,864 +51,250	+13%	+$500K	﹤0.01%	2967
2022 Q1	$3.76M	Buy	385,614 +135,614	+54%	+$1.32M	﹤0.01%	3241
2021 Q4	$2.42M	Buy	+250,000	New	+$2.45M	﹤0.01%	3597

Other funds holding ORIA

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Millennium Management's ORIA Position: Q1 2023 in Review

Millennium Management sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q1 2023, closing a stake of 625,504 shares — an estimated $6.29M sold.

Millennium Management first reported a position in ORIA in Q4 2021 and held it in 5 quarters. The position peaked at $6.29M in Q4 2022. 49 funds tracked by Wall St. Rank hold ORIA as of Q1 2023.

Millennium Management reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Millennium Management sold 625,504 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q1 2023, an estimated $6.29M.
Millennium Management first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q4 2021 and held it in 5 quarters.
Millennium Management's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $6.29M in Q4 2022.
49 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.